Intero Biosystems Inc.

Funding and NIH signals

• NIH award NIH awarded $350K (SBIR Phase I 1R43TR006331-01, new, notice Jul 14, 2026); 2 NIH awards totaling $1.4M in the last 12 months. NIH RePORTER 1R43TR006331-01 (Jul 14, 2026)
  Evidence (2 events)

  • Jul 14, 2026 · NIH RePORTER 1R43TR006331-01
    Organization: INTERO BIOSYSTEMS INC.; City/State: Aurora, CO; Project number: 1R43TR006331-01; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-07-14; FY total cost (award amount): 349824; Administering IC: National Center for Advancing Translational Sciences; Project title: A Novel Human Intestinal Organoid Platform with Peristaltic Function for Drug Discovery and Pre-Clinical Testing in GI Motility Disorders; Organization type: Domestic For-Profits
  • Jul 7, 2026 · NIH RePORTER 2R44TR005379-02
    Organization: INTERO BIOSYSTEMS INC.; City/State: Aurora, CO; Project number: 2R44TR005379-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-07-07; FY total cost (award amount): 1046897; Administering IC: National Center for Advancing Translational Sciences; Project title: A Novel Multi-Lineage Human Intestinal Organoid Screening Platform for Drug Discovery and Preclinical Testing; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals